NTA Vol. 2C:
The "Guideline on the Packaging Information of medicinal products for human use authorised by the Community" - so called "Blue-Box…
Marketing authorisation holders are reminded to be prepared for the possibility of a "hard" Brexit"!
The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.
The BASG authorises and monitors the conduct of clinical trials with medicinal products and medical devices.
The Austrian Pharmacopoeia (ÖAB) is a national addendum to the European Pharmacopoeia and is currently being revised by the ÖAB Commission.